Could a butyrate cream soothe eczema in kids without steroids?
NCT ID NCT07016087
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special cream containing a butyrate releaser (a substance that helps the skin barrier) in 100 children aged 6-36 months with eczema. The cream was compared to a standard moisturizer over 12 weeks. The goal was to see if it could reduce eczema severity and improve skin health, offering a potential steroid-free option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a cream containing a butyrate releaser (postbiotic N-(1-carbamoyl-2-phenyl-ethyl) butyramide)
- What this could lead to
- If it works, this could offer a safe, non-steroid option to ease eczema symptoms and reduce flare-ups in young children.
- What could go wrong
- This is a small, completed trial with no phase designation, so results may not be conclusive. The cream is a cosmetic, not a drug, so effects may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Traslational Medical Science - University of Naples Federico II
Naples, Naples, 80131, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm severe eczema when creams fall short?
- Can a new biologic calm severe eczema?
- Can a daily probiotic soothe colicky babies and calm eczema?
- Can a new injection match an existing eczema treatment?
- Can Real-World data unlock better skin disease care?
- Can a meditation app soothe teen eczema?